z-logo
Premium
Radiocopper for the imaging of copper metabolism
Author(s) -
Hueting Rebekka
Publication year - 2014
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3155
Subject(s) - copper , chemistry , metabolism , cofactor , copper metabolism , positron emission tomography , efflux , in vivo , biochemistry , enzyme , menkes disease , redox , homeostasis , inorganic chemistry , neuroscience , microbiology and biotechnology , biology , organic chemistry
The redox‐active transition metal copper is an essential trace element for growth and development and serves as a structural or catalytic cofactor for many enzymes in a range of physiological processes. Mammalian copper homeostasis is tightly regulated, and an imbalance in copper metabolism is implicated in various pathological disorders. Radioactive copper isotopes, in particular 64 Cu ( t 1/2  = 12.7 h) and 67 Cu ( t 1/2  = 62.01 h), have made important contributions to the understanding of copper metabolism in health and disease. This review gives a brief account of how radiolabelled copper(II) salts and bioreductive copper complexes have been used to trace copper uptake, transport and efflux in vitro and in vivo . Recently, positron emission tomography (PET) has emerged as a noninvasive tool to image copper metabolism in living subjects and 64 Cu‐PET is investigated for the study of copper‐related neurological disorders, genetic diseases and cancer. Copyright © 2014 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom